Results 251 to 260 of about 17,462,775 (406)

Interplay of integrins and selectins in metastasis

Molecular Oncology, EarlyView.
Here we review the role of integrins and their interplay with selectins in metastasis. The efficacy of integrin‐targeted therapies may be reduced in tumors where metastasis relies heavily on selectins. In certain tumors, integrins and selectins exhibit a synergistic interaction during intraperitoneal dissemination.
Diana Maltseva, Ashot Nersisyan, Alexander Tonevitsky   +2 more
wiley   +1 more source

Role of Extended White Blood Cell Parameters in Distinguishing Acute Febrile Illnesses. [PDF]

Adv Hematol
Meriyanti T, Aruan M, Ananda GND.
europepmc   +1 more source

FATAL ANEMIA OF UNKNOWN CAUSE IN A CHILD OF FIVE YEARS, WITH UNUSUAL CELLS IN THE BLOOD [PDF]

, 1909
By WILLISTON W. BARKER
openalex   +1 more source

Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry

Molecular Oncology, EarlyView.
Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson, Emma L. Dorward, Kristyn Jurrius, Nathalie Nataren, Markus Tondl, Kay K. Myo Min, Michaelia P. Cockshell, Anahita Fouladzadeh, John Toubia, Mark DeNichilo, Delphine Merino, Claudine S. Bonder   +11 more
wiley   +1 more source

RELATION BETWEEN THE CHLORIDE CONTENT OF THE BLOOD AND ITS VOLUME PER CENT OF CELLS

, 1921
A. Nørgaard, Hermann Gram
openalex   +1 more source

Influence of Streptomycin Solutions on the Interaction Between the Agglutinating Sera and the Corresponding Red Blood Cell Receptors [PDF]

, 1959
M Kout, Z Kubícková
openalex   +1 more source

MET and NF2 alterations confer primary and early resistance to first‐line alectinib treatment in ALK‐positive non‐small‐cell lung cancer

Molecular Oncology, EarlyView.
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu, Ning Ding, Xiaobo Xu, Yedan Chen, Yong Zhang, Jingwen Liu, Jiebai Zhou, Hairong Bao, Donghui Zhang, Yijun Song, Yang Shao, Yuanlin Song   +11 more
wiley   +1 more source

PB2248: CONCOMITANT HEREDITARY SPHEROCYTOSIS AND PYRUVATE KINASE DEFICIENCY IN A SPANISH FAMILY WITH CHRONIC HEMOLYTIC ANEMIA. CONTRIBUTION OF LASER EKTACYTOMETRY TO CLINICAL DIAGNOSIS

HemaSphere, 2022
J.-L. Vives Corrons, E. Krishnevskaya, L. Montllor, V. Leguizamón, M. Garcia Bernal   +4 more
doaj   +1 more source

Complete Blood Cell Count Parameters Predict Mortality in Patients with Hypersensitivity Pneumonitis. [PDF]

Diagnostics (Basel)
Katsaras M, Sotiropoulou V, Manali E, Fouka E, Papakosta D, Bendstrup E, Kolilekas L, Tomos I, Tzilas V, Ntolios P, Steiropoulos P, Papanikolaou I, Gogali A, Kostikas K, Tsiri P, Papaioannou O, Malakounidou E, Theohari E, Christopoulos I, Sampsonas F, Papiris SA, Rovina N, Bouros D, Tzouvelekis A.   +23 more
europepmc   +1 more source

Improved L.E. Cell Test Using Finger-prick Blood [PDF]

, 1957
H. Lempert, G.M. Berlyne
openalex   +1 more source